Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Total Liabilities (2020 - 2023)

Historic Total Liabilities for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $13.3 million.

  • Terns Pharmaceuticals' Total Liabilities rose 4914.53% to $13.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $13.3 million, marking a year-over-year increase of 4914.53%. This contributed to the annual value of $10.1 million for FY2022, which is 2981.85% up from last year.
  • Terns Pharmaceuticals' Total Liabilities amounted to $13.3 million in Q3 2023, which was up 4914.53% from $15.5 million recorded in Q2 2023.
  • Over the past 5 years, Terns Pharmaceuticals' Total Liabilities peaked at $119.8 million during Q3 2020, and registered a low of $6.7 million during Q2 2021.
  • Its 4-year average for Total Liabilities is $30.7 million, with a median of $10.1 million in 2022.
  • Per our database at Business Quant, Terns Pharmaceuticals' Total Liabilities crashed by 9389.19% in 2021 and then skyrocketed by 10338.83% in 2023.
  • Terns Pharmaceuticals' Total Liabilities (Quarter) stood at $23.7 million in 2020, then crashed by 67.23% to $7.8 million in 2021, then rose by 29.82% to $10.1 million in 2022, then surged by 31.53% to $13.3 million in 2023.
  • Its Total Liabilities was $13.3 million in Q3 2023, compared to $15.5 million in Q2 2023 and $13.6 million in Q1 2023.